Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)

v3.4.0.3
Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Revenues:    
Product Revenue $ 738,023 $ 411,714
License Revenue 15,000
License Revenue - Related party 83,333
Total Revenues $ 738,023 510,047
Cost of Sales:    
Product Cost of Sales (200,028) (226,341)
Gross Profit 537,995 283,706
Administrative Expenses 923,560 698,434
Sales and Marketing Expenses 725,324 575,252
Research and Development Expenses 363,292 305,574
Amortization of Non-Current Assets 42,777 64,643
Loss from Operations (1,516,958) (1,360,197)
Other (Income)/Expenses    
Foreign Currency Transaction (Gain)/Loss 2,256 (995)
Interest and Dividend Income $ (10,285) (32,048)
Other Income (5,355)
Total Other Income $ (8,029) (38,398)
Loss Before Income Taxes $ (1,508,929) $ (1,321,799)
Income Tax Benefit
Net Loss Attributable to Common Stockholders $ (1,508,929) $ (1,321,799)
Other Comprehensive Income    
Net Unrealized Gains on Marketable Securities 8,534 26,713
Total Other Comprehensive Income 8,534 26,713
Comprehensive Loss $ (1,500,395) $ (1,295,086)
Basic & diluted loss per common share $ (0.28) $ (0.26)
Weighted average basic & diluted common shares outstanding 5,425,045 5,125,837